BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Immunology and inflammation

  AbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectations

  AbbVie is eyeing regulatory filings in 2027 for the skin disease drug lutikizumab after clearing multiple endpoints in a late-stage trial, but the results have disappointed some analysts, raising questions about its commercial prospects.

  October 22, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• 

  Cancer

  ESMO 2026: Merck, Moderna shares fall as cancer vaccine disappoints after data leak

  A combination of the personalized cancer vaccine intismeran autogene and Merck’s Keytruda just barely cleared analysts’ expectations for recurrence-free survival, leaving questions as to its applicability to tumor types beyond melanoma.

  October 22, 2026

   · 

  5 min read

   · 

  Annalee Armstrong
• Press Releases

  PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement

  October 22, 2026

   · 

  5 min read